These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 21470168)

  • 1. Chemogenomic approaches for the exploration of GPCR space.
    Weill N
    Curr Top Med Chem; 2011; 11(15):1944-55. PubMed ID: 21470168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and validation of a novel protein-ligand fingerprint to mine chemogenomic space: application to G protein-coupled receptors and their ligands.
    Weill N; Rognan D
    J Chem Inf Model; 2009 Apr; 49(4):1049-62. PubMed ID: 19301874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-pharmacology analysis of G protein-coupled receptors.
    Briansó F; Carrascosa MC; Oprea TI; Mestres J
    Curr Top Med Chem; 2011; 11(15):1956-63. PubMed ID: 21851335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Applications of machine learning in GPCR bioactive ligand discovery.
    Jabeen A; Ranganathan S
    Curr Opin Struct Biol; 2019 Apr; 55():66-76. PubMed ID: 31005679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thematic Analysis™: a chemogenomic approach to GPCR drug discovery.
    Crossley R; Macritchie JA; Slater MJ
    Curr Top Med Chem; 2011; 11(15):1925-43. PubMed ID: 21470170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemogenomics of allosteric binding sites in GPCRs.
    Gloriam DE
    Drug Discov Today Technol; 2013; 10(2):e307-13. PubMed ID: 24050282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. G protein-coupled receptor transmembrane binding pockets and their applications in GPCR research and drug discovery: a survey.
    Kratochwil NA; Gatti-McArthur S; Hoener MC; Lindemann L; Christ AD; Green LG; Guba W; Martin RE; Malherbe P; Porter RH; Slack JP; Winnig M; Dehmlow H; Grether U; Hertel C; Narquizian R; Panousis CG; Kolczewski S; Steward L
    Curr Top Med Chem; 2011; 11(15):1902-24. PubMed ID: 21470172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel chemogenomics analysis of G protein-coupled receptors (GPCRs) and their ligands: a potential strategy for receptor de-orphanization.
    van der Horst E; Peironcely JE; Ijzerman AP; Beukers MW; Lane JR; van Vlijmen HW; Emmerich MT; Okuno Y; Bender A
    BMC Bioinformatics; 2010 Jun; 11():316. PubMed ID: 20537162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging Approaches to GPCR Ligand Screening for Drug Discovery.
    Kumari P; Ghosh E; Shukla AK
    Trends Mol Med; 2015 Nov; 21(11):687-701. PubMed ID: 26481827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structures of G protein-coupled receptors reveal new opportunities for drug discovery.
    Cooke RM; Brown AJ; Marshall FH; Mason JS
    Drug Discov Today; 2015 Nov; 20(11):1355-64. PubMed ID: 26303408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ligand and decoy sets for docking to G protein-coupled receptors.
    Gatica EA; Cavasotto CN
    J Chem Inf Model; 2012 Jan; 52(1):1-6. PubMed ID: 22168315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GLIDA: GPCR-ligand database for chemical genomic drug discovery.
    Okuno Y; Yang J; Taneishi K; Yabuuchi H; Tsujimoto G
    Nucleic Acids Res; 2006 Jan; 34(Database issue):D673-7. PubMed ID: 16381956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. From purified GPCRs to drug discovery: the promise of protein-based methodologies.
    Alkhalfioui F; Magnin T; Wagner R
    Curr Opin Pharmacol; 2009 Oct; 9(5):629-35. PubMed ID: 19443270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A chemogenomic analysis of the transmembrane binding cavity of human G-protein-coupled receptors.
    Surgand JS; Rodrigo J; Kellenberger E; Rognan D
    Proteins; 2006 Feb; 62(2):509-38. PubMed ID: 16294340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A ligand's view of target similarity: chemogenomic binding site-directed techniques for drug discovery.
    Garland SL; Gloriam DE
    Curr Top Med Chem; 2011; 11(15):1872-81. PubMed ID: 21470171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modeling and Deorphanization of Orphan GPCRs.
    Diaz C; Angelloz-Nicoud P; Pihan E
    Methods Mol Biol; 2018; 1705():413-429. PubMed ID: 29188576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Established and In-trial GPCR Families in Clinical Trials: A Review for Target Selection.
    Saikia S; Bordoloi M; Sarmah R
    Curr Drug Targets; 2019; 20(5):522-539. PubMed ID: 30394207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. QSAR modeling of GPCR ligands: methodologies and examples of applications.
    Tropsha A; Wang SX
    Ernst Schering Found Symp Proc; 2006; (2):49-73. PubMed ID: 17703577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterizing common substructures of ligands for GPCR protein subfamilies.
    Erguner B; Hattori M; Goto S; Kanehisa M
    Genome Inform; 2010; 24():31-41. PubMed ID: 22081587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GLIDA: GPCR--ligand database for chemical genomics drug discovery--database and tools update.
    Okuno Y; Tamon A; Yabuuchi H; Niijima S; Minowa Y; Tonomura K; Kunimoto R; Feng C
    Nucleic Acids Res; 2008 Jan; 36(Database issue):D907-12. PubMed ID: 17986454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.